Citigroup Inc Eli Lilly & CO Call Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $16.6 Million - $20.6 Million	-21,500 Reduced 24.68%	65,600 $58.1 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $25.8 Million - $32.4 Million	-35,600 Reduced 29.01%	87,100 $78.9 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $4.8 Million - $6.42 Million	-8,100 Reduced 6.19%	122,700 $95.5 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $29.7 Million - $35 Million	-56,500 Reduced 30.17%	130,800 $76.2 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $42.1 Million - $58 Million	96,800 Added 106.96%	187,300 $101 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $14.6 Million - $19.6 Million	41,700 Added 85.45%	90,500 $42.4 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $1.8 Million - $2.12 Million	-5,800 Reduced 10.62%	48,800 $16.8 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $18.4 Million - $21.4 Million	-57,100 Reduced 51.12%	54,600 $20 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $23.5 Million - $26.8 Million	79,200 Added 243.69%	111,700 $36.1 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $3.51 Million - $4.12 Million	12,600 Added 63.32%	32,500 $10.5 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $15.5 Million - $19.2 Million	-66,000 Reduced 76.83%	19,900 $5.7 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $1.8 Million - $2.23 Million	-8,000 Reduced 8.52%	85,900 $23.7 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $20.8 Million - $25.6 Million	93,900 New	93,900 $21.7 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.